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Abstract Lipids are an important component of total
parenteral nutrition (TPN), contributing the largest
caloric load per volume of solution and providing
essential fatty acids necessary for survival. However,
lipids are known to be causative factors in oxidative
stress, which are expressed via the Bcl-2 family of pro-
teins and/or Fas-mediated apoptosis in several tissues.
Interestingly, we have recently observed an increase in
hepatocyte apoptosis with administration of TPN. To
address the mechanism of this apoptosis, we investigated
the effects of parenteral lipid administration on apop-
totic signaling in a mouse model. C57BL/6J male mice
received physiologic saline and standard chow (control)
or standard TPN solution with (TPN+L) or without
lipid (TPN-L) emulsion. After 7 days of infusion,
apoptosis increased in the TPN+L at a significantly
higher rate compared with control and TPN-L groups
(p <0.05). Both TPN, with and without lipids, sup-
pressed the pro-apoptotic signals Bid and Bcl-xs
(p <0.05). In contrast, TPN with lipid increased the
expression of Fas and both the pro-apoptotic factor Bad
and the anti-apoptotic factor Bcl-xl (p <0.05). These
changes may contribute to TPN-induced hepatocyte
injury (apoptosis) or suppress the ability of liver hepa-
tocytes to regenerate.
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Introduction
Lipids are an important component of total parenteral
nutrition (TPN). Fat emulsions are particularly valuable
in pediatric TPN because they provide an isotonic
solution rich in calories. Clinically, fat-free TPN may
rapidly lead to essential fatty acid deficiency. [1, 2, 3, 4,
5]. Therefore, parenteral administration of essential
phospholipids, via lipid emulsions, is critical [6]. Addi-
tionally, the inclusion of lipid emulsions with TPN
prevents hepatic steatosis [7, 8, 9] and is useful for
hepatic regeneration after partial hepatectomy [10].
Despite the need for lipids, lipid administration may
have several potential problems. Lipid uptake is known
to stimulate macrophages and thereby plays a role in
lung tissue inflammation seen in response to long-term
lipid-based TPN in pigs [11]. Additionally, TPN-associ-
ated cholestasis has been reported to increase signifi-
cantly in patients administered lipids as part of their TPN
regimen [7]. Additionally, lipid emulsions are known to
be causative factors in mitochondrial oxidative stress,
which is expressed via the Bcl-2 family of proteins and/or
Fas-mediated apoptosis in liver tissues [12, 13, 14, 15, 16].
A major intracellular signaling pathway for apoptosis is
mediated by the Bcl-2 family of proteins. Members of
this family can either function to prevent apoptosis (Bcl-
2, Bcl-xl, Bcl-w) or support intracellular apoptotic sig-
naling (Bax, Bak, Bid, Bad, Bcl-xs).
We have recently observed an increase in hepatocyte
apoptosis with TPN administration using a mouse
model, similar to the increase in intestinal epithelial cell
apoptosis and resulting in villus atrophy [17]. However,
the mechanism responsible for this increase in hepato-
cyte apoptosis is not clear. Because lipid administration
has been associated with the development of TPN-
associated cholestasis [18], we hypothesized that the
observed increase in hepatocyte apoptosis may be due in
part to the inclusion of lipids. To address the mechanism
of this TPN-associated apoptosis seen in liver tissue, we
investigated the expression of various pro-apoptotic and
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anti-apoptotic factors. We hypothesized that the hepa-
tocyte apoptosis observed with TPN administration
would be associated with an increase in pro-apoptotic
signals and a concomitant decrease in anti-apoptotic




C57BL/6J male, 10–12-week-old, specific pathogen-free mice
(Jackson Laboratories, Bar Harbor, ME) weighing 23–25 g were
housed in metabolic cages and underwent an acclimatization period
of 1 week. They were fed standard chow and had access to tap water
ad libitum. The mice were maintained in a 12:12-hr day/night
rhythm at a constant temperature of 23ºC and a relative humidity of
40–60%. They were anesthetized with 50 mg/kg of sodium pento-
barbital intraperitoneally. A silastic rubber catheter (0.012 inch i.d. ·
0.025 inch o.d., Konigsberg Instruments, Pasadena, CA) was in-
serted into the superior vena cava through the left jugular vein,
tunneled subcutaneously, and brought out through the skin of the
midscapular regionwith a swivel spring. This set-up allowed themice
freedom of movement in their metabolic cages (Metamount System,
Instech, PlymouthMeeting,MA). Catheterizedmice were connected
to an infusion pump (AIM pain provider pump, donated by Abbott
Laboratories, Abbott Park, IL), and saline (dextrose 5% in 0.45%
normal saline with 20 mEq KCl/L) was infused at an initial rate of
9.6 ml/day. After 24 h the animals were randomized into the fol-
lowing three groups: The control group received the same intrave-
nous physiologic saline solution at 7ml/24 h, in addition to standard
laboratory mouse chow and water ad libitum. The TPN-treated
groups received either standard TPN solution with (TPN+L) or
without lipid (TPN-L) emulsion intravenously at 7 ml/24 h with no
enteral nutrition. The TPN solution contained a balancedmixture of
amino acids and dextrose in addition to electrolytes, trace elements,
and vitamins. Caloric delivery was based on caloric intake mea-
surements from previous investigators so that caloric and protein
delivery was essentially the same for the three groups. Caloric
delivery was compensated by an increased delivery of dextrose. After
7 days of total continuous infusion, blood was collected for liver
biochemistry tests, and the mice were sacrificed using CO2. Whole
liver samples were harvested and sliced into approximately equal
quantities and stored at -70C until examination.
Apoptosis detection
Hepatocyte apoptosis was detected by the TUNEL staining kit
according to the manufacturer’s instructions (in situ cell death
detection (POD) kit, Roche Diagnostic, Penzberg, Germany).
Apoptosis was expressed as the number of positive cells per 200
hepatocytes examined using a microscope.
Liver biochemical assays
Aspartate aminotransferase (AST), alanine aminotransferase
(ALT), alkaline phosphatase (alk phos), cholesterol, glucose and
gamma glutamyltransferase (G-GGT) were measured by standard
assay techniques (Ektachem 750 system, Johnson and Johnson, New
Brunswick, NJ) using mouse serum, stored at -70C until assay.
mRNA expression
mRNA expression of apoptotic factors was measured by semi-
quantitative reverse transcriptase polymerase chain reaction
(RT-PCR) techniques. Liver total cellular RNA was obtained using
TRIzol Reagent (Gibco BRL, Gaithersburg, MD), according to the
manufacturer’s instructions, and purified RNA samples were
stored at -70C until examination. Next, 5 lg of RNA was added to
an RT mixture (total volume 28 lL) of 5 lL of 10· PCR buffer II
(Perkin-Elmer Roche, Foster City, CA), 10lL of 25 mM MgCl2
(Perkin-Elmer Roche, Foster City, CA), 5lL of 10 mM dNTPs
(Roche Molecular Biochemicals, Indianapolis, IN), 1.5lL of 40U
RNAase inhibitor (Roche Molecular Biochemical, Indianapolis,
IN), 4lL of 50lM Oligo (dT)12–18 (Gibco BRL, Gaithersburg,
MD), and 2.5lL of 200U/lL M-MLV reverse transcriptase (Gibco
BRL, Gaithersburg, MD). The sample mixtures were incubated at
40ºC for 70 min and at 95ºC for 3 min and stored at 4ºC until the
polymerase chain reaction {PCR). The PCR mixture contained 1
lL each of 5 lM primer pair [17], 0.8 lL of 10· PCR buffer, 0.2 lL
of 25 mM MgCl2, and 0.1 lL of 5 IU/lL Ampli Taq DNA poly-
merase (Perkin-Elmer Roche, Foster City, CA), with sufficient
DEPC-treated water to bring the mixture to a total volume of 6 lL.
Primer pairs were designed with an optimization program (Oligo
4.1, National Biosciences, Plymouth, MN) and were based on the
GeneBank accession number [17] for the appropriate mouse
mRNA sequence. Thermocycler settings were 94ºC for 15 s, 55ºC
for 15 s, and 72ºC for 1 min for each primer pair. To ensure that
the DNA product was examined at the exponential portion of the
PCR curve, the following number of cycles was used for each
mRNA: 26 cycles for Fas, Fas-L, Bad, Bax and Bcl-xl; 35 cycles for
bak, Bcl-xs, Bid, Bcl-w, Bak and Bcl-2. b-actin expression (equal
number of PCR cycles to the respective transporter gene) was also
generated for each sample as a control. The PCR products were
applied to a 2% agarose gel for 1 h at 160 volts. PCR products were
imaged, and results are expressed relative to the expression of b-
actin.
Statistical analysis
Results are expressed as the mean ± SD. Data analysis was per-
formed using unpaired t -tests and one-way analysis of variance,
with p <0.05 considered significant. Post-hoc intergroup analysis
was performed using Bonferroni t -tests.
Results
Physiologic changes in the mouse
The TPN+L group had a lower 7-day survival rate
(71%) compared with the control group (100%) and the
TPN-L group (83%). Liver wet weight was the same in
both TPN groups (0.8±0.1 g) and was significantly
decreased compared with the control group (1.3±0.2 g;
p <0.05). Serum biochemical parameters are shown in
Table 1. In the TPN+L group, AST levels (640±252 U/
L, p <0.05) were increased significantly compared with
controls (139±50 U/L) and TPN-L groups (130±54 U/
L; p <0.05). Other laboratory values of note consisted
of an elevated glucose level in the TPN-L group but
normal cholesterol and G-GTP levels in all groups
(Table 1).
Hepatocyte apoptosis
Hepatocyte apoptosis, expressed as a ratio of positive
cells per 200 hepatocytes using TUNEL staining, was
relatively infrequent in all histologic specimens. How-
225
ever, there was a significant and almost two-fold increase
in hepatocyte apoptosis in the TPN+L group
(0.56±0.03) compared with both control (0.24±0.06)
and TPN-L groups (0.35±0.07; p <0.05) (Fig. 1).
To help identify the potential mechanisms involved in
the development of this increased hepatocyte apoptosis,
we then examined the expression of a number of factors
responsible for mediating hepatocyte apoptosis.
mRNA expression of Fas/ Fas-L mRNA expression
Fas mRNA expression significantly increased 1.5 times in
the TPN+L group (2.30±0.27, p<0.05) compared with
the control (1.75±0.11) and TPN-L groups (1.52±0.16).
Fas-L mRNA expression was not significantly different
among any of the groups studied (Fig. 2).
mRNA expression of pro-apoptotic factors
of the Bcl-2 protein family
The expression of the pro-apoptotic factor Bid signifi-
cantly decreased in both TPN groups (TPN-L,
0.37±0.15; TPN+L, 0.46±0.20) compared with the
control group (0.71±0.29; p <0.05) (Table 2, Fig. 2).
The expression of the pro-apoptotic factor Bcl-xs also
significantly decreased in both TPN groups (TPN-L,
0.74±0.22; TPN+L, 0.77±0.11) compared with the
control group (1.18±0.40; p <0.05). In contrast, the
pro-apoptotic factor Bad significantly increased in
the TPN+L group (0.79±0.24) compared with both the
control (0.16±0.06) and the TPN-L groups (0.22±0.05;
p <0.05).
mRNA expression of anti-apoptotic factors
of the Bcl-2 protein family
The expression of the anti-apoptotic factor Bcl-xl sig-
nificantly increased in the TPN+L group (0.46±0.08)
compared with both the control group (0.26±0.08) and
the TPN-L group (0.29±0.04; p <0.05). Bcl-w expres-
sion did not change following treatment in any of the
groups. Although Bcl-2 is typically a strong anti-apop-
totic factor, it is not normally expressed in hepatocytes,
and we did not detect appreciable levels in our experi-
ments (Fig. 3).
Fig. 1a–b Hepatocyte apoptosis by TUNEL staining, expressed as
the number of positive cells per 200 hepatocytes, increased in the
TPN+L. a Representative histologic sections from the three
experimental groups. Note the dark cells representing apoptotic
hepatocytes (arrows). Also note that in this figure there are no
apoptotic cells in the control group. bGraphic display of the results
of TUNEL staining. Results are given as the mean ± SD
Fig. 2 mRNA expression of pro-apoptotic factors of the Bcl-2
protein family. The expression of the pro-apoptotic factors Bid and
Bcl-xs significantly decreased in both TPN groups, and Bad
increased in the TPN+L group. * p <.05
Table 1 Serum biochemical parameters from mice in each treat-
ment group (AST aspartate aminotransferase, ALT alanine
aminotransferase, Alk phos alkaline phosphatase, G-GTP gamma-
guanosine 5’-triphosphate)
Parameter Control TPN+Lipids TPN-Lipids
AST (U/l) 139±50 640±252a 130±54
ALT(U/l) 51±12 74±21 73±26
Alk phos(U/l) 28±12 27±13 39±20
G-GTP(U/l) 17±5 22±8 12±4
Glucose 143±47 125±30 140±50




It is known that lipid emulsions suppress the chemo-
tactic function of monocytes in the presence of severe
sepsis. Thus, the infusion of fat emulsions may lead to a
further deterioration of immunologic function in septic
individuals or in those at risk for infection [19, 20]. In
our study, the TPN+L group had a lower 7-day survival
rate compared with the survival rates of the control and
TPN-L groups. Recently, lipid emulsions have been
shown to be causative factors in mitochondrial oxidative
stress as manifested by increased rates of apoptosis [12,
13, 14, 15, 16]. Morphological liver examination in our
TPN+L models demonstrated increased apoptosis. A
major intracellular signaling pathway for apoptosis is
known to be mediated by the Bcl-2 family of proteins.
Pro-apoptotic proteins of the Bcl-2 family act on mito-
chondria and facilitate the release of cytochrome c [12,
13, 15, 21]. In our models, the expression of Bid signif-
icantly decreased in both TPN groups in spite of in-
creased Fas expression. Fas stimulation results in
normal activation of caspase-3, which has been reported
to be arrested in Bid-deficient mice [22]. Esposti et al.
suggest that some pro-apoptotic proteins including Bid
have an intrinsic capacity of binding and exchanging
lipids and lysolipids with mitochondrial membranes [22].
Administration of TPN with lipids might lead to
disruption of the signal in normal liver tissue, causing a
dysfunction in the lipid exchange within mitochondrial
membranes. Our TPN models may have inactivated Bid
signals, resulting in non-stimulation of the Fas-caspase
pathway. The mitochondrial signal pathway is known to
closely correlate with cell cycle arrest, cell apoptosis,
and/or cell death. We have previously reported that
administration of TPN with lipids results in an arrest of
the hepatocyte cell cycle (unpublished data). While the
serum lipid pattern of livers exposed to TPN with lipids
is normal, the phospholipid fraction contains an
abnormal fatty acid pattern consistent with the devel-
opment of essential fatty acid deficiency [23]. The exact
physiologic significance of this is unknown, but it is
tempting to speculate that changes in integrity of the
hepatic cell membrane as a result of this abnormal fatty
acid pattern might account for some of the clinical
abnormalities of hepatic function seen during TPN
administration [23]. The pro-apoptotic factor (Bad) and
anti-apoptotic factor (Bcl-xl) were significantly increased
in the TPN+L group. The activation of Bad has been
reported to promote the suppression of anti-apoptotic
signals by binding to Bcl-xl or Bcl-2. It is known that the
role of Bcl-xl is that of an anti-inflammatory mediator in
macrophages and immature CD4+CD8+ thymocytes
[24, 25]. In our model, the Bcl-xl expression might cor-
relate with increasing macrophage activity after the
administration of lipids in TPN models, because the li-
pid emulsion is known to lead to the suppression of
immunologic function [1, 2, 3, 4, 5]. Further investiga-
tion of this problem is warranted. In addition to the
lipids themselves, other contaminating factors could also
play an essential role. The potential etiology of these
changes may also be due to the associated phytosterols
that are present in most commercial lipids and that have
been suggested to contribute to the development of
TPN-associated cholestasis [18].
In conclusion, TPN, both with and without lipids,
suppressed the pro-apoptotic signals Bid and Bcl-xs in a
mouse model. TPN administration might lead to liver
dysfunction by interrupting such cell signal pathways.
TPN with lipids activated Fas, the pro-apoptotic factor
Bad, and the anti-apoptotic factor Bcl-xl, and induced
histological apoptosis. These changes may also con-
tribute to TPN-induced hepatocyte injury (apoptosis) or
suppress the ability of liver hepatocytes to regenerate.
We hope that future work will direct the use of safer
Table 2 mRNA expression of pro- and anti-apoptotic factors of the Bcl-2 protein family (data presented as mean ± SD). Results of
hepatocyte apoptosis (see Fig. 1) as expressed as the number of apoptotic hepatocytes per 200 cells is shown in the final column for
comparison
Group Bid Bcl-xs Bax Bcl-w Bad Bcl-xl Apoptosis
Control 0.71±0.29 1.18±0.40 1.13±0.29 0.57±0.19 0.16±0.06 0.26±0.08 2.4±0.6
TPN-L 0.37±0.15a 0.74±0.22a 0.99±0.17 0.42±0.21 0.22±0.05 0.29±0.04 3.5±0.7
TPN+L 0.46±0.20a 0.77±0.11a 1.41±0.35 0.57±0.27 0.79±0.24a,b 0.46±0.08a,b 5.6±0.3a
aCompared with control group,
bcompared with TPN-L group; p<0.05, using ANOVA with post-hoc analysis between groups
Fig. 3 mRNA expression of anti-apoptotic factors of the Bcl-2
protein family. The anti-apoptotic factor Bcl-xl significantly
increased in the TPN+L group. * p <.05
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TPN solutions that will have fewer deleterious effects on
hepatocytes.
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